High dose chemotherapy in advanced ovarian carcinoma with bulky residual disease

被引：0
|
作者：
Heron, JF
Lhomme, C
Kerbrat, P
Mayer, F
Chevallier, B
Goupil, A
Vennin, P
Lebrun, D
Chauvergne, J
Ayme, Y
Namer, M
机构：
[1] FRENCH COMPREHENS CANC CTR,CAEN,FRANCE
[2] FRENCH COMPREHENS CANC CTR,VILLEJUIF,FRANCE
[3] FRENCH COMPREHENS CANC CTR,RENNES,FRANCE
[4] FRENCH COMPREHENS CANC CTR,DIJON,FRANCE
[5] FRENCH COMPREHENS CANC CTR,ROUEN,FRANCE
[6] FRENCH COMPREHENS CANC CTR,ST CLOUD,FRANCE
[7] FRENCH COMPREHENS CANC CTR,LILLE,FRANCE
[8] FRENCH COMPREHENS CANC CTR,REIMS,FRANCE
[9] FRENCH COMPREHENS CANC CTR,BORDEAUX,FRANCE
[10] FRENCH COMPREHENS CANC CTR,MARSEILLE,FRANCE
[11] FRENCH COMPREHENS CANC CTR,NICE,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [31] High-dose chemotherapy - High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results
    Salerno, MG
    Ferrandina, G
    Greggi, S
    Pierelli, L
    Menichella, G
    Leone, G
    Scambia, G
    Mancuso, S
    BONE MARROW TRANSPLANTATION, 2001, 27 (10) : 1017 - 1025
  • [32] High dose chemotherapy in ovarian cancer
    Pujade-Lauraine, E
    Curé, H
    Battista, C
    Guastalla, JP
    Chiurazzi, B
    Fabbro, M
    Tubiana-Mathieu, N
    Bourgeois, H
    Lioure, B
    Paraiso, D
    Lotz, JP
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 : 64 - 67
  • [33] EXCISION OF PARAAORTIC BULKY DISEASE IN A PATIENT WITH ADVANCED OVARIAN CANCER AFTER TREATMENT WITH 3 CYCLES OF NEOADJUVANT CHEMOTHERAPY
    Mitsopoulos, V.
    Biliatis, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A668 - A668
  • [34] Dose-dense chemotherapy in advanced ovarian cancer
    Bookman, Michael A.
    LANCET, 2009, 374 (9698): : 1303 - 1305
  • [35] The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review
    Timmermans, M.
    van der Hel, O.
    Sonke, G. S.
    Van de Vijver, K. K.
    van der Aa, M. A.
    Kruitwagen, R. F.
    GYNECOLOGIC ONCOLOGY, 2019, 153 (02) : 445 - 451
  • [36] ADVANCED MINIMAL RESIDUAL OVARIAN-CARCINOMA - ABDOMINO-PELVIC IRRADIATION FOLLOWING COMBINATION CHEMOTHERAPY
    HAINSWORTH, JD
    MALCOLM, A
    JOHNSON, DH
    BURNETT, LS
    JONES, HW
    GRECO, FA
    OBSTETRICS AND GYNECOLOGY, 1983, 61 (05): : 619 - 623
  • [37] HIGH-DOSE MEDROXYPROGESTERONE ACETATE FOR THE TREATMENT OF ADVANCED OVARIAN-CARCINOMA
    TROPE, C
    JOHNSSON, JE
    SIGURDSSON, K
    SIMONSEN, E
    CANCER TREATMENT REPORTS, 1982, 66 (06): : 1441 - 1443
  • [38] High-dose chemotherapy with autologous stem cell support in advanced ovarian cancer
    Grenman, SE
    Rantanen, VT
    Salmi, TA
    ANNALS OF MEDICINE, 1996, 28 (02) : 151 - 158
  • [39] SENSITIVITY OF MINIMAL RESIDUAL DISEASE VS ADVANCED EVALUABLE DISEASE IN IDENTIFYING CHEMOTHERAPEUTIC BENEFITS IN OVARIAN CARCINOMA
    EDMONSON, JH
    FLEMING, TR
    DECKER, DG
    JORGENSEN, EO
    MALKASIAN, GD
    JEFFERIES, JA
    WEBB, MJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 178 - 178
  • [40] SEQUENTIAL COMBINATION CHEMOTHERAPY OF ADVANCED OVARIAN-CARCINOMA
    GUNALE, SR
    MURALI, MS
    YODER, AS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 430 - 430
12345